Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Below is a condensed transcript of that exchange, in which Kennedy and Sanders spoke over each other and repeated themselves: ...

Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Harmony Biosciences’ (HRMY) recently released growth plans and pipeline advancements have showcased the company’s dedication ...

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange ...